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Abstract This study investigated the changes in intra-
cellular [Ca2?]i (intracellular calcium ion concentration)
and TRPC6 (transient receptor potential channel 6)
expression during angiotensin II (AngII)-induced glomer-
ular mesangial cell (GMC) proliferation, as well as the
inhibitory effect of losartan. GMC cultures were split into
four groups treated for 24 h: Group N (blank control
group), Group A (10-7 mol/L AngII), Group LT
(10-7 mol/L AngII and 10-5 mol/L losartan), and Group
Pred (10-7 mol/L AngII and 10-5 mol/L prednisone).
GMCs proliferation was measured by the MTT and trypan
blue assays. The distribution of TRPC6 was monitored by
immunofluorescence, the expression of TRPC6 was
detected by RT-PCR and Western blotting, and [Ca2?]i was
measured by laser scanning confocal microscopy. The
results showed that the maximal proliferation of GMCs was
induced by treatment with 10-7 mol/L AngII for 24 h. In
Group A, the distribution of TRPC6 was not uniform in the
cell membrane, there was increased accumulation of this
protein within the cytoplasm, and the increased expression
of TRPC6 and [Ca2?]i was consistent with the proliferation
of cells. In Group LT, losartan inhibited the proliferation of
GMCs significantly, the levels of TRPC6 and [Ca2?]i were
diminished, and the distribution of TRPC6 was improved.
Prednisone also significantly inhibited the proliferation of
GMCs and had no effects on the expression of TRPC6 and
[Ca2?]i in Group Pred. These findings suggested that AngII
could enhance the expression of TRPC6, increase [Ca2?]i,
and demonstrate a time–dose–response relationship with
the proliferation of GMCs, while losartan reversed the
effect of AngII on GMC proliferation.
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Introduction
In the past 20 years, epidemiological studies have sug-
gested an increase in the incidence of chronic kidney dis-
ease in children [1]. Glomerulosclerosis is a pathological
condition commonly found in chronic kidney diseases of
different causes and is characterized by glomerular mes-
angial cell (GMC) proliferation and extracellular matrix
(ECM) deposition. Therefore, there are numerous studies
regarding GMC proliferation-related factors, which are
important for making progress toward the reversal of glo-
merular injury.
Transient receptor potential channel (TRPC) is a trans-
membrane protein that allows for transmembrane move-
ment of Ca2?. TRPC6 is the core member of TRPC
superfamily [2, 3], which maintains normal kidney func-
tion by regulating [Ca2?]i (intracellular calcium ion con-
centration) and is involved in a number of kidney diseases
[4, 5].Changes in intracellular calcium signaling pathways
caused by mutations or abnormal expression of TRPC6
lead to various kidney proliferation diseases [6], such as
focal segmental glomerulosclerosis (FSGS), minimal
change disease (MCD), and membranous glomerulone-
phritis (MGN). These observations suggest that the rela-
tionship between TRPC6 and Ca2? is of great significance
for the proliferation type of kidney diseases. Angiotensin II
(AngII) can activate multiple signaling pathways through
the AngII type I receptor (AT1R) and is involved in the
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regulation of TRPC6 as well as upregulating the expression
of chemotactic factor, fibroblast growth factor, and adhe-
sion molecule, thus contributing to pathological processes
such as cell proliferation, inflammation, and fibrosis [7–9].
Previous research had shown that TRPC6 can promote the
increase of AngII-related Ca2? through AT1R to enhance
damage caused by AngII [10]. Therefore, studies of the
relationship among GMC ion channels [Ca2?]i and the
involvement of ion channels in cell proliferation have
become hot topics. In this study, GMC proliferation
induced by AngII was observed. The expression of TRPC6
at the gene and protein level, as well as the relationship
between cell proliferation and [Ca2?]i in the GMC prolif-
eration process, was further investigated. Furthermore, the
blocking effects of losartan were studied, and the mecha-
nism of cell proliferation induced by AngII was explored
from the perspective of ion channels.
Materials and methods
GMC proliferation and MTT (methyl thiazolyl
tetrazolium) assay
Glomerular mesangial cells (HBZY-1, Experimental Ani-
mal Center in Sun Yat-sen University, China) were cul-
tured in incubators containing 5 % CO2 at 37 C and grew
adherently in 20 % fetal bovine serum medium (Gibco,
USA). Morphology was observed with an inverted micro-
scope. GMCs at logarithmic growth stage were inoculated
into six-well plates, fixed with paraformaldehyde for
30 min, and then blocked by goat serum (Gibco, USA) for
1 h. Afterward, GMCs were incubated with mouse mono-
clonal antibodies (1:50, Wuhan Boster, China), including
anti-desmin protein, anti-a-actin protein, anti-myosin
protein, anti-vimentin protein, anti-keratin protein, and
anti-factor VIII at 4 C overnight. This was followed by
inoculation with FITC-labeled goat anti-mouse IgG (1:32,
Invitrogen, USA) at 37 C for 1 h. GMCs were monitored
and visualized by fluorescence microscopy. GMCs of 3–8
generations were used for further experiments.
Cells were inoculated into 96-well plates. In the serum-
free medium, cells adhered to the surface, and different
concentrations of AngII (Sigma, USA), including 0 (blank
control group), 10-8 and 10-7, 10-6 and 10-5 mol/L, were
used to stimulate the GMCs for 0, 24, 48, and 72 h,
respectively. Next, 10 lL of MTT (5 mg/mL, Sigma,
USA) was added to each well and incubated at 37 C for
4 h; afterward, 150 lL of dimethyl sulfoxide (DMSO) was
added to each well. The optical density (OD) at 490 nm
was measured by a microplate reader. After mixing the
cells with a 0.4 % trypan blue solution (9:1, Wuhan Boster,
China)for 3 min, the number of living cells and dead cells
were counted with a hemocytometer. Proliferation rate (%)
was calculated with the following formula: (OD value in
AngII group - OD value in blank control group)/OD value
in blank control 9 100 %. Cell viability (%) was calcu-
lated with the following formula: number of living cells/
(number of living cells ? number of dead cells) 9 100 %.
After determining the optimal concentration and time of
AngII treatment (10-7 mol/L of AngII to induce GMC
proliferation for 24 h), the experiments were grouped as
follows: Group N (blank control group), Group A
(10-7 mol/L AngII), Group LT (10-7 mol/L AngII and
10-5 mol/L losartan), and Group Pred (10-7 mol/L AngII
and 10-5 mol/L prednisone). Intervention groups (Group
LT and Group Pred) were pre-treated by losartan or pred-
nisone, respectively, for 1 h prior to the addition of AngII.
Inhibition rate (%) was calculated with the following for-
mula: (OD value in group A - OD value in intervention
group)/OD value in group A 9 100 %.
Distribution and expression of TRPC6
Immunofluorescence staining
Cells in different groups were fixed with paraformalde-
hyde, blocked with goat serum (Gibco, USA), and mixed
with rabbit anti-mouse TRPC6 polyclonal antibody
(1:1000, Alomone Labs, Israel). After overnight incuba-
tion, FITC-labeled goat anti-rabbit IgG (1:200, Santa Cruz,
USA) was added, and the distribution of TRPC6 was
observed by immunofluorescence microscopy.
Reverse transcription and real-time PCR
Total RNA was extracted with the addition of Trizol
reagent (Invitrogen, USA) into all groups. cDNA was
synthesized using 1–2 lg of total RNA. The primers were
designed using the Primer Express software (Primer Pre-
mier 5.0) based on sequences obtained with the GenBank
accession numbers. The sequences of the primers and
amplicon sizes are shown in Table 1. PCR amplification
consisted of one cycle at 95 C for 30 s, followed by 40
cycles at 95 C for 5 s and 60 C for 20 s. Agarose gel
electrophoresis was employed to analyze PCR products.
Optical density analysis with glyceraldehyde-3-phosphate
dehydrogenase (GAPDH, Invitrogen, USA) serving as an
internal reference was used to measure mRNA expression
in all groups.
Western blotting
Cell lysis solution was added into the cells of each group.
The protein concentration was determined by the bicinch-
oninic acid (BCA) method. Thirty five micrograms of total
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protein was denatured at 100 C for 5 min, run on a 120 g/
L sodium dodecyl sulfate polyacrylamide gel (SDS-PAGE,
Invitrogen, USA) for 1.5 h, and then wet transferred to a
polyvinylidene difluoride (PVDF, Invitrogen, USA) mem-
brane. The membrane was blocked with 5 % non-fat milk
at room temperature for 30 min, followed by incubation
with rabbit anti-mouse TRPC6 polyclonal antibody
(1:1000, Alomone Labs, Israel) at 4 C overnight. The
membrane was subsequently incubated with HRP-labeled
goat anti-rabbit IgG (1:5000, Wuhan Boster, China) at
room temperature for 1 h. After the final rinse, the mem-
brane was visualized with an enhanced chemiluminescence
reagent and exposed to X-ray films. Band intensity was
estimated using Gel-Pro image analysis software. The
relative expression levels of target proteins were calculated
as the ratio of the target protein band intensity to that of the
internal control GAPDH.
Intracellular [Ca2?]i
Cells from each group were re-suspended with
5 9 10-6 mol/L of Fluo-3AM (Invitrogen, USA) at 37 C
for 45 min. Following this step, cells were inoculated into
special culturing dishes for laser scanning confocal
microscope (LSCM) and washed with D-Hanks three
times. Then, the measurements were taken by LSCM with
the excitation wavelength set at 488 nm. The [Ca2?]i was
scanned per 5 s for 10 min, with each scan covering 20
cells. The results were analyzed by Zeiss image 4.2 soft-
ware. The [Ca2?]i was calculated with the following for-
mula: F/Fa (F: real-time fluorescence intensity; Fa: basic
fluorescence intensity).
Statistical analyses
All values were expressed as mean ± SD, and analysis of
variance was calculated using SPSS 11.5 statistical analysis
software. Fisher’s LSD test was used for the pairwise
comparison. A P value \0.05 was considered to be sta-
tistically significant.
Results
Morphology and identification of GMC
GMCs grew adherently and showed larger soma with
fusiform, irregular star-shaped, or elongated shapes. There
were several dendrites of various lengths on the cell, which
connected the cell groups into a network with a round- or
egg-shaped cell nuclei in the middle. The GMCs stained
positive for desmin, a-Actin, myosin, and vimentin and
negative for keratin and factor VIII, indicating that the
cultured cells were in fact GMCs (Fig. 1).
Cell proliferation results
There was no obvious cell proliferation induced by the
addition of 10-8 mol/L AngII, while addition of 10-7,
10-6, and 10-5 mol/L of AngII caused increased cell
proliferation at 24, 48, and 72 h; the proliferation at 24 h
was much more significant than that at 48 h and 72 h
(P \ 0.01, P \ 0.05). In addition, at 24 h, the proliferation
with AngII at 10-7 mol/L was of greater statistical sig-
nificance than that observed with AngII at 10-8, 10-6, and
10-5 mol/L (P \ 0.01) (Table 2). After staining with try-
pan blue, dead cells turned into the color of light blue while
living cells kept unchanged in color. The cell viability for
cells treated with 10-7 mol/L AngII at 24 h was 91–95 %,
while cell viabilities of 80–86 and 60–68 % were observed
when cells were treated with 10-6 and 10-5 mol/L of
AngII, respectively. Compared with Group N, the increases
in GMC proliferation in Group A, Group LT, and Group
Pred were statistically significant (P \ 0.01, P \ 0.05).
Furthermore, compared with Group A, the GMC prolifer-
ation was significantly inhibited in Group LT and Group
Pred (39.5 and 49.6 %, P \ 0.05) (Table 3).
TRPC6 expression
TRPC6 distribution
In Group N, TRPC6 was detected mostly in the cell
membrane, where it was uniformly distributed and showed
little staining in the cytoplasm (Fig. 2a). After introduction
of AngII for 24 h (Group A), the distribution of TRPC6
was no longer homogeneous in the membrane, and some
region showed a lack of TPRC6 staining; additionally,
Table 1 Real-time PCR primer sequences and amplicon sizes




TRPC6 F: TGG CAA GTC CAG CAT
ACC TGT C
178 NM 053559
(Rattus) R: GTG TTT CTG CAG AGG
TCC AGG AG
GAPDH F: GGC ACA GTC AAG GCT
GAG AAT G
143 NM 017008
(Rattus) R: ATG GTG GTG AAG ACG
CCA GTA
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more TRPC6 was detected in cytoplasm, and even particles
were observed (Fig. 2b). Compared with Group A, after
treatment by losartan (Group LT), the distribution of
TRPC6 was more uniform and improved (Fig. 2c). After
the incubation with prednisone (Group Pred), the distri-
bution of TRPC6 was similar to that observed in Group A,
with some regions along cell membrane missing TPRC6
and more appearing in cytoplasm (Fig. 2d).
TRPC6 mRNA expression
The expression of TRPC6 mRNA and GAPDH mRNA was
measured (Fig. 3). Compared with Group N, the expression
of TRPC6 at the mRNA level in Group A, Group LT, and
Group Pred was elevated (P \ 0.01); when compared with
Group A, the expression of TRPC6 mRNA in Group LT
was diminished (P \ 0.01), and there existed no significant
difference in Group Pred (P [ 0.05) (Fig. 5).
Fig. 1 Images of immunofluorescence staining for GMC (9400). a Desmin(?); b a-Actin(?); c Myosin(?); d Vimentin(?); e Keratin(-);
f Factor VIII (-) (Blue color was DAPI nuclei staining, the target protein(-)) (color figure online)
Table 2 Changes in GMC proliferation induced by AngII (mean ± SD)
Groups (mol/L) 0 h 24 h 48 h 72 h
0 0.147 ± 0.016 0.230 ± 0.021 0.161 ± 0.020 0.162 ± 0.017
10-8 0.149 ± 0.013 0.298 ± 0.014 (29.6 %) 0.217 ± 0.018 (34.4 %) 0.202 ± 0.015 (92.3 %)
10-7 0.152 ± 0.027 0.699 ± 0.012 (203.6 %)**##44abc 0.349 ± 0.025 (116.1 %)** 0.470 ± 0.016 (189.8 %)**
10-6 0.152 ± 0.018 0.411 ± 0.021 (78.6 %)*#4 0.330 ± 0.022 (104.4 %)* 0.291 ± 0.019 (79.6 %)*
10-5 0.151 ± 0.022 0.421 ± 0.019 (83.1 %)*#4 0.338 ± 0.019 (109.7 %)* 0.281 ± 0.018 (73.5 %)*
(%) Proliferation rate; versus Group 0 mol/L, * P \ 0.05, ** P \ 0.01; Group 24 h versus 48 h, # P \ 0.05, ## P \ 0.01; Group 24 h versus
72 h, 4 P \ 0.05, 44 P \ 0.01; Group 24 h 10-7 versus 24 h 10-8
a P \ 0.01; Group 24 h 10-7 versus 24 h 10-6, b P \ 0.01; Group 24 h 10-7 versus 24 h 10-5, c P \ 0.01
Table 3 Inhibitory effects of losartan and prednisone on GMC pro-
liferation (mean ± SD)
Groups 24 h Inhibition rate
(%)
N 0.224 ± 0.020
A (AngII 10-7 mol/L) 0.691 ± 0.019**
LT (AngII 10-7 mol/L ? LT
10-5 mol/L)
0.418 ± 0.021*# 39.5 %
Pred (AngII 10-7 mol/L ?
Pred-5 mol/L)
0.348 ± 0.018*# 49.6 %
Versus Group N, * P \ 0.05, ** P \ 0.01; versus Group A, # P \ 0.05
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TRPC6 protein expression
The proteins measured by immunoblotting were the
106 kDa TRPC6 protein and the 37 kDa GAPDH protein
(Fig. 4). The expression of the TRPC6 protein in Group A,
Group LT, and Group Pred was higher than that in Group N
(P \ 0.01); as compared with Group A, the expression of
TRPC6 protein in Group LT declined (P \ 0.01), and no
significant difference in Group Pred was observed
(P [ 0.05) (Fig. 5).
Changes of [Ca2?]i
After incubation with Fluo-3AM, a calcium indicator,
green fluorescence was uniformly distributed in cells
(Fig. 6). The [Ca2?]i increased significantly after the
addition of AngII. The fluorescence intensity began to
increase at the third min and peaked at the fourth minute.
The fluorescence began to decrease 1 min later and
returned to the starting level at the eighth minute (Fig. 7).
At the fourth min, [Ca2?]i in Group A, Group LT, and
Group Pred were higher than that in Group N (P \ 0.01);
as compared with Group A, [Ca2?]i decreased in Group LT
(P \ 0.05), and there was no significant difference in
Group Pred (P [ 0.05).
Discussion
The characteristic pathological features of early-stage
glomerulosclerosis are excessive proliferation of GMCs
and secretion of large amounts of ECM in the glomerulus,
Fig. 2 Distribution images of TRPC6 in GMC (9600). a Group N:
TRPC6 was uniformly distributed in cell membrane and cytoplasm,
most in cell membrane and few in cytoplasm; b Group A: TRPC6
distribution was not continuous along membrane, with some mem-
brane region missing of TPRC6; more TRPC6 appeared in cytoplasm,
even particles can be observed; c Group LT: TRPC6 distribution was
more uniform and improved than that in group A; d Group Pred:
TRPC6 distribution was similar as in group A, with some regions
along cell membrane missing and more in cytoplasm
Fig. 3 Expression of GMC TRPC6 mRNA in different groups.
1 Group N; 2 Group A; 3 Group LT; 4 Group Pred
Fig. 4 Electrophoresis for TRPC6 protein of GMC in different
groups. 1 Group N; 2 Group A; 3 Group LT; 4 Group Pred
Fig. 5 The analysis of TRPC6 mRNA and protein of GMC in
different groups. Versus Group N, *P \ 0.01; versus Group A,
#P \ 0.01
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which eventually leads to glomerulosclerosis-induced renal
failure. As the main active substances in the kidney, AngII
can enhance the mRNA and protein expression of trans-
forming growth factor-beta and fibrinolytic enzyme acti-
vator inhibitor, causing GMC proliferation and ECM
accumulation that gradually leads to glomerulosclerosis.
In this study, the cell proliferation was indirectly
measured by the methyl thiazolyl tetrazolium assay, which
detected the activity of mitochondrial metabolic enzymes,
in order to measure AngII-induced GMC proliferation.
The results showed that at concentrations of 10-7, 10-6,
and 10-5 mol/L, AngII promoted the proliferation of
GMCs during the 0–48 h time frame after treatment; there
was an apparent time–dose–response relationship, espe-
cially for 10-7 mol/L AngII at 24 h. When the concen-
tration of AngII was increased to 10-5 mol/L, which was
at 72 h, the cell proliferation delayed, which indicated that
AngII affected not only cell proliferation, but also cell
apoptosis. AngII receptors mainly include AT1R and
AT2R; AT1R mainly affects cell proliferation and smooth
muscle contraction, while AT2R affects cell apoptosis and
smooth muscle relaxation [11]. Within certain concentra-
tions of AngII, AT1R in GMCs plays the leading role, so
the effect of AngII is mainly cell proliferation. At higher
concentrations, where the number of AngII exceeds the
number of AT1R binding sites, the function of AT2R
comes into play. In this study, when compared with Group
Pred, losartan significantly inhibited proliferation of
GMCs, which suggested that by blocking the binding
between AngII and AT1R, cell proliferation could be
effectively inhibited.
Intracellular Ca2? is as an important second messenger
in the process of cell proliferation, and the changes in
concentration trigger the transduction of growth-related
signals. An increase of [Ca2?]i can promote the prolifera-
tion of GMCs; for example, AngII can increase [Ca2?]i by
signal transduction pathways, which in turn regulates cell
proliferation [12, 13]. After treatment with a calcium
chelator, the increase of [Ca2?]i and the proliferation of
GMCs are significantly inhibited [14]. The same inhibitory
effect was shown for losartan in this study. Store-operated
calcium channels (SOCC) participate in signal transduction
as major regulators of Ca2? internal flow in kidney micro-
vascular smooth muscle cells and GMCs. TRPC1/3/4/6 of
GMCs are candidates for SOCC [15]. Through SOCC and
other types of calcium channels, AngII can affect intra-
cellular Ca2?, thereby regulating renal microcirculation
and GMC functions [16].
Fig. 6 Distribution of [Ca2?]i for GMC at 4 min and 8 min (9400). a Group N at 4 min; b Group A at 4 min; c Group LT at 4 min; d Group
Pred at 4 min; e Group N at 8 min; f Group A at 8 min; g Group LT at 8 min; h Group Pred at 8 min
Fig. 7 Changes of [Ca2?]i in GMC in different groups
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In this study, it was observed that AngII not only stimu-
lated the proliferation of GMCs, but also significantly
affected the distribution of TRPC6 and its expression at the
mRNA and protein level. Measurements with a confocal
microscope indicated that [Ca2?]i reached the maximum
level at the forth minute after incubation with AngII. These
observations suggested that TRPC6 and Ca2? played
important roles in the process of GMC proliferation. After
incubation with losartan, TRPC6 distribution was improved,
and [Ca2?]i was consistent with the cell proliferation, indi-
cating that AngII affected TRPC6 and Ca2? through AT1R,
and further regulated cell proliferation. Prednisone inhibited
cell proliferation, but had no effect on the expression of
TRPC6 and [Ca2?]i, indicating that cell proliferation was not
necessarily caused by changes in [Ca2?]i. It had been
reported that glucocorticoid does not cause the changes in
[Ca2?]i, and that its effects on cell proliferation could be
achieved by inhibiting nuclei factor NF-jB or increasing P21
protein to arrest the cell cycle of GMCs at G0/G1 [17, 18].
AngII promoted the increase of [Ca2?]i in GMCs, which
in turn induced its proliferation. The mechanism by which
this occurs begins with the binding of AngII to AT1R on
the surface of GMCs, which causes phospholipase c (PLC)
to catalyze the cleavage of 4,5-phosphatidyl inositol
diphosphate (PIP2), producing 1,4,5-inositol triphosphate
(IP3). IP3 can then activate Ca2? channels, leading the flow
of extracellular Ca2? into the cell. This influx results in
increased [Ca2?]i in the sarcoplasm, which in turn regulates
transcription and causes the proliferation of GMCs. There
exist target sites for AngII on the TRPC6 channel. Through
TRPC6, [Ca2?]i can be increased by AngII stimulation.
And it is possible that TRPC6 and AngII are relevant in
terms of regulating GMC proliferation via controlling
[Ca2?]i [19]. In the case of receptor-regulating TRPC6
signaling pathways, high IP3 causes the release of sensitive
calcium stores that further activate TRPC6, which leads an
influx of Ca2? into the cells to fill the calcium stores, so
TRPC6 is considered a candidate for SOCC and plays the
role of a SOCC [20]. These studies suggested that the
mechanism by which AngII promoted the increase of
[Ca2?]i and induced GMC proliferation shared similarities
with the mechanism by which TRPC6 regulated [Ca2?]i, as
both were associated with an IP3-regulated calcium chan-
nel, and TRPC6 mediated Ca2? to flow inward to promote
the proliferation of GMCs.
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